sulmazole has been researched along with Coronary Disease in 11 studies
sulmazole: structure given in first source
sulmazole : An imidazopyridine that is 1H-imidazo[4,5-b]pyridine which is substituted at position 2 by a 2-methoxy-4-(methylsulfinyl)phenyl group. An A1 adenosine receptor antagonist, it was formerly used as a cardiotonic agent.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colle, JP | 1 |
| Ohayon, J | 1 |
| Ledain, L | 1 |
| Besse, P | 1 |
| Stauch, M | 2 |
| Sigel, H | 2 |
| Seibold, H | 1 |
| Nechwatal, W | 2 |
| Bambach, T | 1 |
| Thormann, J | 5 |
| Schlepper, M | 5 |
| Kramer, W | 5 |
| Gottwik, M | 2 |
| Kindler, M | 1 |
| Gottwick, M | 1 |
| Weikl, A | 1 |
| Kohlschütter, S | 1 |
| Durst, OE | 1 |
| Lang, E | 1 |
| Pozenel, H | 1 |
| Ruffmann, KD | 1 |
| Mehmel, HC | 1 |
| Kübler, W | 1 |
1 trial available for sulmazole and Coronary Disease
| Article | Year |
|---|---|
Assessment of left ventricular function from the mitral valve echocardiogram following positive and negative inotropic interventions.
Topics: Adolescent; Adult; Aged; Aortic Coarctation; Cardiac Pacing, Artificial; Coronary Angiography; Coron | 1983 |
10 other studies available for sulmazole and Coronary Disease
| Article | Year |
|---|---|
[Hemodynamic effects of a new positive inotropic agent (AR-L 115 BS) in ischemic and nonischemic myocardiopathies].
Topics: Adult; Aged; Cardiac Catheterization; Cardiotonic Agents; Coronary Disease; Female; Heart Failure; H | 1984 |
The effect of AR-L 115 BS on left ventricular function in patients with coronary heart disease and dilated cardiomyopathy.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Catheterization; Cardiac Volume; Cardiomyopath | 1983 |
Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia.
Topics: Angina Pectoris; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiotonic Agents; Coronary D | 1983 |
Hemodynamic and myocardial energetic changes induced by the new cardiotonic agent, AR-L 115, in patients with coronary artery disease.
Topics: Cardiotonic Agents; Coronary Disease; Electrocardiography; Exercise Test; Heart Ventricles; Hemodyna | 1982 |
[Mechanism and effects of the cardiotonic AR-L 115 BS in coronary heart disease: improved ventricular function and regional wall motility without angina pectoris].
Topics: Cardiotonic Agents; Coronary Circulation; Coronary Disease; Heart Function Tests; Heart Ventricles; | 1982 |
AR-L115BS in the treatment of heart failure.
Topics: Adult; Coronary Disease; Heart Failure; Hemodynamics; Humans; Imidazoles; Middle Aged; Myocardial Co | 1982 |
Hemodynamic effects of single-dose administration of AR-L 115 BS in patients with coronary artery disease.
Topics: Adult; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiotonic Agents; Coronary Disease | 1981 |
Ergometric and hemodynamic studies on a new cardiotonic agent AR-L 115 BS.
Topics: Angina Pectoris; Cardiotonic Agents; Coronary Disease; Female; Heart Diseases; Hemodynamics; Humans; | 1981 |
A new orally active positive inotropic substance: AR-L 115 BS.
Topics: Blood Pressure; Cardiotonic Agents; Coronary Disease; Hemodynamics; Humans; Imidazoles | 1981 |
[Hemodynamics and metabolic-energetic expenses of the influence of AR-L115 in patients with coronary artery disease (author's transl)].
Topics: Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Electrocardiography; Energy Meta | 1981 |